Armin W. Mäder
Founder at Qvanteq AG
Profile
Armin W.
Mäder is the founder and Chairman of Qvanteq AG, a company founded in 2009.
He is currently the Director at Neurotune AG.
Dr. Mäder has previously served as Chairman & Chief Executive Officer at Memo Therapeutics AG, Chief Operating Officer at AC Immune SA, and Chief Financial Officer at Institut Straumann AG.
He holds a graduate and doctorate degree from the Swiss Federal Institute of Technology and an MBA from the International Institute for Management Development.
Armin W. Mäder active positions
| Companies | Position | Start |
|---|---|---|
Neurotune AG
 Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Director/Board Member | - |
Qvanteq AG
 Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Founder | 2008-12-31 |
Former positions of Armin W. Mäder
| Companies | Position | End |
|---|---|---|
| AC IMMUNE SA | Chief Operating Officer | - |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Chief Executive Officer | - |
Institut Straumann AG
 Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Director of Finance/CFO | - |
Training of Armin W. Mäder
| International Institute for Management Development | Masters Business Admin |
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private companies | 4 |
|---|---|
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
Institut Straumann AG
Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Health Services |
Memo Therapeutics AG
Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Health Technology |
Qvanteq AG
Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Armin W. Mäder
